TITLE

Restrictive cardiomyopathies

AUTHOR(S)
Nihoyannopoulos, Petros; Dawson, David
PUB. DATE
December 2009
SOURCE
European Journal of Echocardiography;Dec2009, Vol. 10 Issue 8, piii23
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Restrictive cardiomyopathies constitute a heterogenous group of heart muscle conditions that all have, in common, the symptoms of heart failure. Diastolic dysfunction with preserved systolic function is often the only echocardiographic abnormality that may be noted, although systolic dysfunction may also be an integral part of some specific pathologies, particularly in the most advanced cases such as amyloid infiltration of the heart. By far, the majority of restrictive cardiomyopathies are secondary to a systemic disorder such as amyloidosis, sarcoidosis, scleroderma, haemochromatosis, eosinophilic heart disease, or as a result of radiation treatment. The much more rare diagnosis of idiopathic restrictive cardiomyopathy is supported only by the absence of specific pathology on either endomyocardial biopsies or at post-mortem. Restrictive cardiomyopathy is diagnosed based on medical history, physical examination, and tests: such as blood tests, electrocardiogram, chest X-ray, echocardiography, and magnetic resonance imaging. With its wide availability, echocardiography is probably the most important investigation to identify the left ventricular dysfunction and should be performed early and by groups that are familiar with the wide variety of aetiologies. Finally, on rare occasions, the differential diagnosis from constrictive pericarditis may be necessary.
ACCESSION #
47451754

 

Related Articles

  • Impact of new electrocardiographic criteria in arrhythmogenic cardiomyopathy. Hauer, Richard N. W.; Cox, Moniek G. P. J.; Groeneweg, Judith A. // Frontiers in Physiology;Sep2012, Vol. 3, p1 

    Arrhythmogenic cardiomyopathy (AC) has originally been described as a disorder characterized by fibrofatty replacement of the myocardium, primarily of the right ventricle (RV), and ventricular tachyarrhythmias, sudden death, and at a late stage progressive heart failure. Arrhythmogenic right...

  • Cardiac Amyloidosis Responding to Bortezomib: Case Report and Review of Literature. Charaf, Edriss; Iskandar, Said B.; Blevins, Ashley; Abi-Saleh, Bernard; Fahrig, Stephen // Current Cardiology Reviews;2009, Vol. 5 Issue 3, p228 

    We report a case of a 53-year old patient with symptoms of congestive heart failure in whom a restrictive cardiomyopathy and a kappa-chain monoclonal gammopahty were diagnosed. Treatment with eight cycles of Bortezomib, a proteasome inhibitor, resulted in a significant regression of myocardial...

  • Congestive Heart Failure: A Case of Protein Misfolding. Chung-Eun Ha; Bhagavan, Nadhipuram V.; Loscalzo, Miki; Chan, Stephen K.; Huy V. Nguyen; Rios, Carlos N.; Honda, Stacey A. A. // Hawaii Journal of Medicine & Public Health;Jun2014, Vol. 73 Issue 6, p172 

    This article describes an interesting case of a patient presenting with congestive heart failure found to have restrictive cardiomyopathy with initial laboratory evaluation showing hypogammaglobuminemia without a monoclonal band on serum and urine electrophoresis. This case highlights the...

  • The Role of Standard Echocardiographic Parameters in Endomyocardial Biopsy Proven Cardiac Amyloidosis. Biočić, Stanko; Jurinjak, Sandra Jakšić; Vincelj, Josip; Barić, Davor; Manojlović, Spomenka; Brkljačić, Diana Delić // Collegium Antropologicum;2015, Vol. 39 Issue 2, p441 

    Primary light-chain (AL) amyloidosis is a plasma cell dyscrasia associated with the deposition of immunoglobulinderived amyloid in multiple organs. In the heart, this results in an infiltrative cardiomyopathy, with increased left ventricular wall thickness, normal or decreased left ventricular...

  • An Unusual Case of Cardiac Amyloidosis. Garibaldi, Brian; Zaas, David // JGIM: Journal of General Internal Medicine;Jul2007, Vol. 22 Issue 7, p1047 

    Cardiac amyloidosis can result from any of the systemic amyloidoses. The disease is often characterized by a restrictive cardiomyopathy although the particular signs and symptoms depend in part on the underlying cause. In addition to managing the symptoms of heart failure, treatment options vary...

  • Peripartum Cardiomyopathy. Bhattacharyya, Anirban; Basra, Sukhdeep Singh; Sen, Priyanka; Kar, Biswajit // Texas Heart Institute Journal;2012, Vol. 39 Issue 1, p8 

    Peripartum cardiomyopathy is idiopathic heart failure occurring in the absence of any determinable heart disease during the last month of pregnancy or the first 5 months postpartum. The incidence varies worldwide but is high in developing nations; the cause of the disease might be a combination...

  • Use of a comprehensive numerical model to improve biventricular pacemaker temporization in patients affected by heart failure undergoing to CRT-D therapy. Molfetta, A. Di; Santini, L.; Forleo, G. B.; Cesario, M.; Tota, C.; Sgueglia, M.; Sergi, D.; Ferrari, G.; Romeo, F. // Medical & Biological Engineering & Computing;Aug2010, Vol. 48 Issue 8, p755 

    Cardiac resynchronization therapy by biventricular pacemaker/ICD implantation is a validated therapy for patients affected by heart failure with asynchrony of ventricular contraction. Considering the large number of parameters which play a role in cardiac resynchronization therapy, a...

  • Case of the Month. Parker, Tyson // JAAPA: Journal of the American Academy of Physician Assistants (;Jul2009, Vol. 22 Issue 7, p70 

    The article presents the case study of 73 year-old Hispanic male, diagnosed with idiopathic dilated cardiomyopathy (IDC), that is systolic heart faliure (HF). The patient was referred to a series of tests including electrocardiogram (ECG) which demonstrated a sinus tachycardic rhythm with a left...

  • DILATED CARDIOMYOPATHY PRODUCED BY LAMIN A/C GENE MUTATIONS. CERASELA MIHAELA GOIDESCU // Clujul Medical;2013, Vol. 86 Issue 4, p309 

    Lamin A/C gene (LMNA) associated cardiomyopathy is a form of dilated cardiomyopathy with poor prognosis and high mortality, and a rapid evolution toward end-stage heart failure and malignant ventricular arrhythmias associated with increased risk of sudden cardiac death. It is transmitted in a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics